Shares of Dr. Reddy's Laboratories Ltd. 500124 rose 1.89% to 1,269.90 Indian rupees Monday, on what proved to be an ...

Stay up-to-date with the Dr Reddys Stock Liveblog, your trusted source for real-time updates and thorough analysis of a ...

PM, the Sensex was down 369 points (0.46 percent), trading at 81,741.61, while the Nifty50 slipped 102 points (0.41 percent) ...

Shares of Dr. Reddy's Laboratories Ltd. 500124 inched up 0.09% to 1,254.80 Indian rupees Monday, on what proved to be an ...

Stay up-to-date with the Dr Reddys Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a ...

Dr Reddy’s Laboratories (RDY) has released an update. Dr. Reddy’s Laboratories has announced the allotment of 26,150 equity ...

Data from Moneycontrol's Analyst Call Tracker showed that 'buy' ratings for Cipla and Dr Reddy's each increased by one in ...

Dr. Reddy's entered into a licensing and commercialization agreement with Shanghai Junshi Biosciences for toripalimab.

Dr Reddy's Laboratories on Thursday said Kazakhstan revenue authority has levied a penalty of Rs 28.7 lakh on its subsidiary.

Stock Radar: Suraksha Diagnostic, Canara Bank, Nykaa, India Gelatine, Subex, Ramco Systems, GPT Healthcare in focus on Friday Dec 06 2024 01:43 AM Stock Radar: Adani stocks, Dr Reddyu2019s Labs ...

"This is to inform that our step-down wholly owned subsidiary "Dr Reddy’s Laboratories Kazakhstan LLP", has received an order ...

Dr. Reddy's Laboratories aims to strengthen its presence in the Indian market, with CEO M. V. Ramana sharing insights.